IL2RA and cytomegalovirus infection: After adjusting for recipient’s age, CMV infection, HCV antiviral therapy and steroid therapy for ACR, we found that IL-2RA treatment was associated with a three-fold increase in the hazard of progression of fibrosis (Table 2B).